Positron Corporation (POSC) Fair Value 2026

POSC · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.3 /10

32 fundamental signals · 1 models active

Value Trap Risk

SAFE (10/100)

Quick Summary — As of 2026-08-27, Positron Corporation (POSC) trades at $1.68. QOC: 4.3/10. Value Trap Risk: 10/100 (SAFE). 1/13 models active.

Key Facts

Ticker
POSC
Price
$1.68
Quality Score
4.3/10
Value Trap Risk
10/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.3/10 signals weak fundamentals

What Fair Value Does Each Model Give POSC?

1 Intrinsic Value Models vs. Current Price ($1.68)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · High Conviction
 $0.13 -92.5%

All Models Active

All 1 models are displayed above.

What Is Positron Corporation (POSC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Positron Corporation's intrinsic value is estimated at $0.13, suggesting the stock is overvalued at its current price of $1.68. With 1 out of 1 models flagging downside (-92.5% vs price), the market may be pricing in unsustainable growth.

What Do the Models Say About POSC?

1 of 13 models are currently active for POSC. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does POSC Rank in Medical Devices?

Among 157 Medical Devices stocks, POSC ranks #140 by Quality of Company score. CirclFi's QOC score of 4.3/10 evaluates 32 fundamental signals. A score of 4.3 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

As a pharmaceutical industry, Positron Corporation operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating POSC should weigh these sector-specific dynamics alongside our model-derived fair values.

Is POSC a Value Trap?

CirclFi's Value Trap algorithm assigns POSC a score of 10/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Positron Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Positron Corporation's fundamental quality profile registers 4.3/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every POSC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across POSC's 1 active models, average confidence is 51%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Positron Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

ADGMAdagio Medical Holdings, Inc.QOC 4.3NVNOenVVeno Medical CorporationQOC 4.2PMIPicard Medical, Inc.QOC 4.4AMIXAutonomix Medical, Inc.QOC 4.2BJDXBluejay Diagnostics, Inc.QOC 4.4NUMDNu-Med Plus, Inc.QOC 4.2USAQQHSLab, Inc.QOC 8.2RCELAVITA Medical, Inc.QOC 6.7VNRXVolitionRx LimitedQOC 5.7IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: ADGM · NVNO · PMI · AMIX · BJDX · NUMD · USAQ · RCEL · VNRX · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to POSC?

7 companies across all industries closest to POSC’s Quality of Company score of 4.3/10.

SMNRSemnur Pharmaceuticals, Inc.QOC 4.3NEXTNextDecade CorporationQOC 4.3HYMCHycroft Mining Holding CorporationQOC 4.3BRVOBravo Multinational IncorporatedQOC 4.3AIEVThunder Power Holdings, Inc.QOC 4.3FBRXForte Biosciences, Inc.QOC 4.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SMNR · NEXT · HYMC · BRVO · AIEV · FBRX · NVDA

Where Does POSC Sit in CirclFi's Medical Devices Rankings?

POSC is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Positron Corporation’s Valuation?

What is Positron Corporation's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Positron Corporation (POSC). The Quality of Company score is 4.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is POSC overvalued or undervalued right now?

At $1.68, 0 of 1 active models suggest POSC may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits Positron Corporation's business model in Medical Devices.

What does a Quality of Company score of 4.3 mean for POSC?

Positron Corporation's QOC of 4.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on POSC?

CirclFi analyzes POSC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is POSC a value trap in 2026?

Positron Corporation's Value Trap score is 10/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Positron Corporation (POSC) a Quality of Company score of 4.3/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/POSC/ · Methodology
Primary sources for this POSC valuation
  • Financial statements: Positron Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0000844985) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for POSC as of ; valuations recomputed .